Zehua Wu
Papers
3
Total Citations
54
H-Index
3
About
Zehua Wu is a pioneering surgeon-scientist advancing the frontiers of robotic hepatopancreaticobiliary surgery. His primary research focuses on optimizing robotic pancreatoduodenectomy (RPD)—one of the most technically demanding abdominal procedures—through rigorous clinical trials and innovative surgical frameworks. Wu’s major contributions include leading the PORTAL trial, a landmark multicenter phase III non-inferiority randomized controlled study comparing robotic versus open pancreatoduodenectomy for pancreatic and periampullary tumors (44 citations), which aims to establish definitive evidence for robotic approaches. He also developed and validated the first dedicated difficulty scoring system for da Vinci RPD (6 citations), a novel tool that objectively stratifies procedural complexity to guide surgeon training, case selection, and quality improvement. Further demonstrating his technical expertise, Wu reported a large single-center series of 105 robot-assisted retroperitoneal tumor resections (4 citations), showcasing the safety and feasibility of the Da Vinci system in this challenging anatomical niche. With his work bridging surgical innovation, evidence-based validation, and educational frameworks, Zehua Wu is shaping the future of minimally invasive pancreatic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3